Newly released data from the Hong Kong Stock Exchange reveals a notable share purchase.
On June 4th, Chairman of the Board Wu Yifang increased his holdings in EVEREST MED (01952) by 20,000 shares.
The transaction was executed at a price of HK$28.8 per share, resulting in a total investment of HK$576,000.
Following this acquisition, his total shareholding has risen to approximately 2.1602 million shares.
This revised holding now represents a 0.61% stake in the company.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments